What is the current size of the metabolomics market?

The metabolomics market is valued at USD 2.51 billion in 2025 and is projected to reach USD 4.23 billion by 2030. Read More

Which product segment leads the metabolomics market?

Bioinformatics tools and services lead with 40.87% revenue share in 2024 and exhibit an 11.87% CAGR outlook. Read More

Why is Asia-Pacific considered the fastest-growing region?

Localized instrument manufacturing in China and expanding clinical-research capacity in India push Asia-Pacific to a 13.78% CAGR through 2030. Read More

How are hospitals adopting metabolomics?

Hospitals and diagnostic labs are integrating validated metabolite panels for disease monitoring, growing at an 11.72% CAGR due to clearer regulatory guidance. Read More

What technological advances are accelerating the field?

Next-generation mass spectrometry platforms offering 10-fold sensitivity gains and AI-powered annotation tools drastically reduce analysis time and broaden application scope. Read More

Which indications show the highest growth potential?

Neurological disorders lead future growth with a 16.11% CAGR, driven by advances in early-stage Alzheimer’s and Parkinson’s biomarkers. Read More

Metabolomics Companies

This report lists the top Metabolomics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Metabolomics industry.

Global Metabolomics Market

Access Report

About This Report
- Market Size & Share
- Market Analysis
- Trends and Insights
- Segment Analysis
- Geography Analysis
- Competitive Landscape
- Major Players
- Recent Developments
Table of Contents
SCOPE OF THE REPORT
Market Definition